ZA737973B - Antidepressive compounds and process for their preparation - Google Patents

Antidepressive compounds and process for their preparation

Info

Publication number
ZA737973B
ZA737973B ZA737973A ZA737973A ZA737973B ZA 737973 B ZA737973 B ZA 737973B ZA 737973 A ZA737973 A ZA 737973A ZA 737973 A ZA737973 A ZA 737973A ZA 737973 B ZA737973 B ZA 737973B
Authority
ZA
South Africa
Prior art keywords
preparation
antidepressive
compounds
antidepressive compounds
Prior art date
Application number
ZA737973A
Other languages
English (en)
Inventor
H Corrodi
P Berntsson
P Carlsson
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of ZA737973B publication Critical patent/ZA737973B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA737973A 1972-11-16 1973-10-12 Antidepressive compounds and process for their preparation ZA737973B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7214872A SE373850B (fr) 1972-11-16 1972-11-16

Publications (1)

Publication Number Publication Date
ZA737973B true ZA737973B (en) 1974-10-30

Family

ID=20299803

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA737973A ZA737973B (en) 1972-11-16 1973-10-12 Antidepressive compounds and process for their preparation

Country Status (17)

Country Link
JP (1) JPS5732058B2 (fr)
AR (1) AR204160A1 (fr)
AT (1) AT333278B (fr)
BE (1) BE806228A (fr)
CA (1) CA976553A (fr)
CH (1) CH586679A5 (fr)
DE (1) DE2356017A1 (fr)
DK (1) DK137898B (fr)
ES (1) ES420359A1 (fr)
FI (1) FI55652C (fr)
FR (1) FR2206942B1 (fr)
GB (1) GB1429068A (fr)
IE (1) IE38516B1 (fr)
NL (1) NL7315294A (fr)
SE (1) SE373850B (fr)
SU (1) SU482945A3 (fr)
ZA (1) ZA737973B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7909514L (sv) 1979-11-16 1981-05-17 Astra Laekemedel Ab Nya halofenyl-pyridyl-allylaminderivat

Also Published As

Publication number Publication date
DK137898C (fr) 1978-11-20
CA976553A (en) 1975-10-21
GB1429068A (en) 1976-03-24
FR2206942A1 (fr) 1974-06-14
IE38516B1 (en) 1978-03-29
FR2206942B1 (fr) 1977-01-28
FI55652C (fi) 1979-09-10
DK137898B (da) 1978-05-29
AT333278B (de) 1976-11-10
CH586679A5 (fr) 1977-04-15
JPS5732058B2 (fr) 1982-07-08
AR204160A1 (es) 1975-11-28
AU6216573A (en) 1975-05-08
NL7315294A (fr) 1974-05-20
ATA938573A (de) 1976-03-15
BE806228A (fr) 1974-02-15
FI55652B (fi) 1979-05-31
DE2356017A1 (de) 1974-06-06
IE38516L (en) 1974-05-16
ES420359A1 (es) 1976-04-01
JPS49133379A (fr) 1974-12-21
SE373850B (fr) 1975-02-17
SU482945A3 (ru) 1975-08-30

Similar Documents

Publication Publication Date Title
YU36975B (en) Process for obtaining dimethyl-2-oxo-3-phenoxypropylphosphonate
IL42219A0 (en) 14-hydroxymorphinan derivatives and processes for their preparation
YU36527B (en) Process for obtaining 3-hydroxy-cephalosporin
YU133872A (en) Process for obtaining diphenyl-alkanoylamino-pyridines
EG10850A (en) Process for the preparation of 1-hydroxy-pyridones
ZA739694B (en) New substituted cyclopropylamines process for their preparation and pharmaceutical preparation
GB1407649A (en) Process for the preparation of thiazole-sulphenamides
YU56979A (en) Process for obtaining d-homosteroids
IL40802A0 (en) Cephalosphorin derivatives and process for their preparation
CH614430A5 (en) Process for the preparation of substituted phenylguanidines
ZA734194B (en) Benzenesulfonyl-ureas and process for their preparation
ZA738587B (en) Process for the preparation of thiazolesulphenamides
ZA731178B (en) Process for the preparation of alpha-6-deoxytetracyclines
YU36149B (en) Process for obtaining isopropylamines
ZA73817B (en) New amino-propane derivatives and process for their preparation
GB1405791A (en) Process for the preparation of pyridoindolobenzazepines
ZA737973B (en) Antidepressive compounds and process for their preparation
YU35619B (en) Process for obtaining rifamycine b
YU318473A (en) Process for obtaining m-dioxane-5-methylamines
YU146973A (en) Process for obtaining oxo-prostaglandins
KR780000152B1 (en) Process for the preparation of 2-amino-benzylamines
GB1405228A (en) Cis-zearalene and its derivatives and process for their preparation
IL43789A0 (en) Novel everninomicin derivatives and process for their preparation
IL42308A0 (en) New process for the preparation of 2-methoxy-5-sulfamoyl benzoyl-n-ethyl-2-pyrrolidine-methylamine
YU240180A (en) Process for obtaining deacetoxy-cephalosporin